Chemed (CHE) Insider Trading & Ownership $444.23 -6.13 (-1.36%) Closing price 03:59 PM EasternExtended Trading$445.50 +1.27 (+0.29%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Chemed (NYSE:CHE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.29%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$158.75KNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$13.19M Get CHE Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CHE Insider Buying and Selling by Quarter Chemed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/4/2025George J Walsh IIIDirectorBuy200$417.10$83,420.00 8/4/2025Nicholas Michael WestfallEVPSell10,012$421.91$4,224,162.92 5/16/2025Spencer S LeeEVPSell1,500$577.99$866,985.00 5/7/2025Spencer S LeeEVPSell1,500$577.86$866,790.00 5/5/2025Kevin J McnamaraCEOSell1,500$576.45$864,675.00 3/31/2025Kevin J McnamaraCEOSell1,000$615.33$615,330.00 3/6/2025Kevin J McnamaraCEOSell2,000$593.67$1,187,340.00 3/6/2025Byron DonaldsU.S. Congress Member (R-FL)Sell$594.36$1,001 - $15,00012/30/2024Brian C JudkinsVPBuy145$519.50$75,327.50 11/27/2024Spencer S LeeEVPSell732$575.62$421,353.84 11/25/2024Kevin J McnamaraCEOSell2,000$572.77$1,145,540.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/26/2024George J Walsh IIIDirectorSell400$597.47$238,988.00 9/26/2024Kevin J McnamaraCEOSell2,000$598.81$1,197,620.00 9/9/2024Nicholas Michael WestfallEVPSell1,713$569.35$975,296.55 8/21/2024George J Walsh IIIDirectorSell200$577.95$115,590.00 8/16/2024Andrea R LindellDirectorSell831$571.51$474,924.81 (Data available from 1/1/2013 forward) CHE Insider Trading Activity - Frequently Asked Questions Who is on Chemed's Insider Roster? The list of insiders at Chemed includes Andrea R Lindell, Brian C Judkins, David Patrick Williams, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, and Spencer S Lee. Learn more on insiders at CHE. What percentage of Chemed stock is owned by insiders? 3.29% of Chemed stock is owned by insiders. Learn more on CHE's insider holdings. Which Chemed insiders have been buying company stock? The following insiders have purchased CHE shares in the last 24 months: Brian C Judkins ($75,327.50), and George J Walsh III ($83,420.00). How much insider buying is happening at Chemed? Insiders have purchased a total of 345 CHE shares in the last 24 months for a total of $158,747.50 bought. Which Chemed insiders have been selling company stock? The following insiders have sold CHE shares in the last 24 months: Andrea R Lindell ($474,924.81), Brian C Judkins ($7,196,910.00), David Patrick Williams ($8,643,274.48), George J Walsh III ($354,578.00), Kevin J Mcnamara ($12,898,735.00), Michael D Witzeman ($1,704,321.00), Nicholas Michael Westfall ($6,322,619.47), Patrick P Grace ($153,638.32), and Spencer S Lee ($4,728,704.29). How much insider selling is happening at Chemed? Insiders have sold a total of 74,511 Chemed shares in the last 24 months for a total of $42,477,705.37 sold. Which members of congress are trading Chemed? Byron Donalds (R-FL) has sold shares of Chemed in the last year totaling $8,000. Chemed Key ExecutivesMr. Kevin J. McNamara (Age 70)CEO, President & Director Compensation: $5.84M3 recent tradesMr. Michael D. Witzeman CPA (Age 53)MBA, VP, Controller, Principal Accounting Officer & CFO Compensation: $1.15MMr. Spencer S. Lee (Age 68)Executive Vice President Compensation: $1.65M2 recent tradesMr. Thomas C. Hutton (Age 73)VP & Director Mr. Nicholas Michael Westfall (Age 45)Executive Vice President Compensation: $2.5M1 recent tradesMs. Lisa A. ReinhardVP, Chief Administrative Officer & SecretarySherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 43)VP, Secretary & Chief Legal Officer More Insider Trading Tools from MarketBeat Related Companies Medpace Insider Selling Labcorp Insider Selling Quest Diagnostics Insider Selling DaVita Insider Selling CorVel Insider Selling Amedisys Insider Selling Pediatrix Medical Group Insider Selling AMN Healthcare Services Insider Selling Cross Country Healthcare Insider Selling Encompass Health Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried? This page (NYSE:CHE) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access